Skip to main content

Acadia Pharmaceuticals Inc

ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001070494

In the last 90 days, Acadia Pharmaceuticals Inc insiders filed 0 open-market purchases and 2 sales; 354 institutions reported holding it in 13F filings for Q2 2026, worth $4.27B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Acadia Pharmaceuticals Inc changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of ACAD: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders2583296+41
Shares156.4M45.5K162.9M+6.53M (+4.2%)
Value$2.41B$700.3K$2.99B+$582.7M (+24.2%)

3 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (70)

Institutions that held Acadia Pharmaceuticals Inc at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to ACAD in Q4 2024
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.2,230,815$40.9M0.11%
Cubist Systematic Strategies, LLC634,520$11.6M0.19%
Great Lakes Advisors, LLC540,013$9.91M0.08%
Burney Co378,903$6.95M0.25%
Prudential Financial Inc253,961$4.66M0.01%
Point72 Europe (London) LLP173,155$3.18M0.18%
Healthcare of Ontario Pension Plan Trust Fund135,100$2.48M0.01%
Cannon Global Investment Management, LLC117,990$2.17M5.36%
Jefferies Financial Group Inc.114,766$2.11M0.02%
Laurion Capital Management LP98,896$1.81M0.11%
Old Mission Capital LLC89,989$1.65M0.04%
Verition Fund Management LLC82,622$1.52M0.01%
Quantedge Capital Pte Ltd76,900$1.41M0.52%
Jain Global LLC72,212$1.33M0.04%
F/M Investments LLC64,660$1.19M0.04%
Graham Capital Management, L.P.61,777$1.13M0.03%
Alpine Global Management, LLC55,566$1.02M0.30%
CTC Alternative Strategies, Ltd.55,133$1.01M1.31%
Aquatic Capital Management LLC50,269$922.4K0.02%
Point72 (DIFC) Ltd43,595$800.0K0.07%
Aster Capital Management (DIFC) Ltd40,609$745.2K0.28%
Virtus Investment Advisers, Inc.39,370$722.4K0.57%
Raymond James Financial Inc36,161$663.6K0.00%
Aviva PLC35,883$658.5K0.00%
Woodline Partners LP26,765$491.1K0.00%
Police & Firemen's Retirement System of New Jersey26,018$477.4K0.00%
Fox Run Management, L.L.C.25,422$466.5K0.08%
Point72 Hong Kong Ltd24,054$441.4K0.03%
KLP Kapitalforvaltning AS20,500$376.2K0.00%
Crawford Fund Management, LLC19,800$363.3K0.24%
Bayforest Capital Ltd17,448$320.2K0.40%
Point72 Asia (Singapore) Pte. Ltd.16,974$311.5K0.08%
JT Stratford LLC15,170$278.4K0.05%
Vinva Investment Management Ltd10,191$273.6K0.01%
Semanteon Capital Management, LP13,177$241.8K0.13%
Personal Cfo Solutions, LLC12,230$224.4K0.04%
Oxford Asset Management LLP11,925$218.8K0.10%
Elo Mutual Pension Insurance Co11,760$215.8K0.00%
JustInvest LLC11,646$213.7K0.00%
Bank of Montreal11,522$211.4K0.00%
CIBC World Markets Corp11,199$205.5K0.00%
Uniting Wealth Partners, LLC11,000$201.8K0.10%
denkapparat Operations GmbH10,626$195.0K0.29%
Tema ETFs LLC10,596$194.4K0.08%
Simplex Trading, LLC10,543$193.0K0.01%
Scientech Research LLC10,401$190.9K0.05%
Xponance, Inc.10,151$186.3K0.00%
Caitong International Asset Management Co., Ltd9,751$178.9K0.18%
Globeflex Capital L P9,155$168.0K0.01%
GF Fund Management Co. Ltd.3,494$64.1K0.00%
R Squared Ltd2,560$47.0K0.05%
Virtus Fund Advisers, LLC2,135$39.2K0.12%
Leonteq Securities AG1,856$34.1K0.00%
Wingate Wealth Advisors, Inc.1,000$18.4K0.02%
Horizon Investments, LLC824$15.1K0.00%
Versant Capital Management, Inc536$9.84K0.00%
Private Wealth Management Group, LLC290$5.32K0.00%
Valley National Advisers Inc260$4.00K0.00%
SBI Securities Co., Ltd.202$3.71K0.00%
Skopos Labs, Inc.188$3.45K0.00%
WPG Advisers, LLC106$1.95K0.00%
True Wealth Design, LLC62$1.14K0.00%
Stonebridge Financial Group, LLC60$1.10K0.00%
Avion Wealth63$1.00K0.00%
Continuum Advisory, LLC51$9360.00%
CVA Family Office, LLC50$9180.00%
Assetmark, Inc37$6790.00%
WealthTrak Capital Management LLC35$6430.00%
Principal Securities, Inc.13$2390.00%
Capital Advisors, Ltd. LLC23$00.00%

Sold out (29)

Institutions that held Acadia Pharmaceuticals Inc at the end of Q3 2024 and filed for Q4 2024 without it.

Not filed for Q4 2024 yet (3)

Institutions that held Acadia Pharmaceuticals Inc at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ACAD in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
B. Metzler seel. Sohn & Co. Holding AG31,405$483.0K
Raymond James & Associates14,119$217.2K
First Personal Financial Services6$93